Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Lung cancer breathalyzer trialed in the UK

Reporter: Aviva Lev-Ari, PhD, RN

Updated on 7/26/2022

VOC – Biomarkers for Disease Diagnosis: Sniffing Out Cancer: Israeli Prof. Finds Diseases Like Cancer And Parkinson’s Can Be Detected On The Breath

Reporter: Aviva Lev-Ari, PhD, RN

https://pharmaceuticalintelligence.com/category/biomarkers-medical-diagnostics/voc-volatile-organic-compounds-as-biomarkers/

See on Scoop.it – Cardiovascular and vascular imaging

With lung cancer survival rates greatly improved by early detection, we’ve seen a number of efforts to develop a better way to detect the disease in its early stages. So-called lung cancer breathalyzers are one technology being developed by a number of research teams, including one from the University of Huddersfield in the UK, which plans to trial a breathalyzer device in pharmacies.

The project to develop the device, which is taking place over three years, involves researching a lung cancer “biomarker signature” that is detectable in breath. Previous studies have already shown that carbon-based sensors embedded with gold nanoparticles and even dogs can detect chemicals in the breath indicating the presence of the disease in the lungs.

See on www.gizmag.com